Advertisement

Organisation › Details
Casdin Capital LLC (Casdin Life Sciences Partners)
![]() |
Start | 2011-01-01 established |
![]() |
Industry | venture capital |
Industry 2 | LIFE SCIENCES | |
![]() |
Person | Casdin, Eli (Casdin Capital 201507 Managing Member) |
![]() |
Region | New York, NY |
Country | United States (USA) | |
Street | 1350 Avenue of the Americas Suite 2405 | |
City | 10019 New York, NY | |
Tel | +1-212-897-5430 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2021-04-07 |
Advertisement

More documents for Casdin Capital LLC (Casdin Life Sciences Partners)
- [1] Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams...
- [2] SomaLogic, Inc.. (12/22/20). "Press Release: SomaLogic Adds $81M to Series A Financing Totaling $214M". Boulder, CO....
- [3] Bayer AG. (12/21/20). "Press Release: Bayer Sells a Facility at Its Wuppertal Site to WuXi Biologics". Wuppertal & Leverkusen....
- [4] DNA Script. (7/29/20). "Press Release: DNA Script Expands Series B to $89M". Paris & South San Francisco, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top